Trade Amgen AMGN

Amgen live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 17, 16:01

SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares

stocks
Julian Parker 2026 Jun 16, 16:03

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

forex
Julian Parker 2026 Jun 16, 16:01

Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

crypto
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 15, 16:02

Silver Price Forecast: XAG/USD Holds Below $70 as Fed Decision Shapes Outlook

commodity
Julian Parker 2026 Jun 15, 16:01

EUR/USD Outlook: Dollar Firms Before Fed Decision as Euro Rally Loses Momentum

forex
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks
Julian Parker 2026 Jun 14, 16:02

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

stocks
Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks

Latest news

Show more
Julian Parker 2026 Jun 17, 16:05

Today's Stock Prices: U.S. Stocks Fall, SpaceX Slides, Allbirds Soars 39%

Stock
Julian Parker 2026 Jun 17, 16:04

Gold Price Today, June 18, 2026: Spot Gold Slides Toward $4,250 as Fed Signals Possible 2026 Rate Hike

gold price today
Julian Parker 2026 Jun 17, 16:04

Brent Oil Price Today: Brent Falls Below $79 as US-Iran Peace Deal Drains War Premium

Commodities
Julian Parker 2026 Jun 17, 16:02

Kevin Warsh’s First Fed Decision Turns Hawkish as Dot Plot Revives 2026 Rate Hike Bets

Forex
Julian Parker 2026 Jun 16, 16:05

Gold Price Today, June 17, 2026: Gold Holds Near One-Week High as Oil Slump Eases Fed Rate-Hike Fears

gold price today
Julian Parker 2026 Jun 16, 16:02

Brent Crude Falls Below $80 as Goldman Sachs and Morgan Stanley Cut Oil Forecasts

Commodities
Julian Parker 2026 Jun 16, 16:01

SpaceX Stock Rally Extends as Options Debut Fuels Post-IPO Surge

Stock
Julian Parker 2026 Jun 15, 16:04

Bank of Japan Raises Interest Rate to 1% as Yen Pressure Persists

Forex

Info

Spread

2.10

Spread (%)

0.6241 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

182205513728

Shares Outstanding

539708274

Earnings Date (Next)

1999-11-22

Div Yield

2026-06-05

Ex-Dividend Date

2026-05-15

Forward annual dividend rate

10.08

Forward annual dividend yield

0.029

EPS

14.37

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 17, 16:03

How to Open a Swap-Free Account: Full Step-by-Step Guide

Julian Parker 2026 Jun 17, 16:01

Is Forex & CFD Trading Halal? The Ultimate Guide to Islamic Trading Account

Julian Parker 2026 Jun 16, 16:04

High-Leverage Forex Brokers: What Traders Need to Know Before Using High Leverage

Trustpilot